West Nile virus affects many animals, but the highest prevalence of morbidity and mortality is observed in birds, horses, and humans. The purpose of this study was to determine a protocol in birds of prey and corvids, using a vaccine developed for horses. The birds were assigned to five groups. Groups 1–4 received 0.25 ml, 0.5 ml, 0.75 ml, and 1.0 ml, respectively, and group 5 served as a control group. The greatest percentage of seroconversion (58.3%) was observed in the vaccine group that received a dose of 1.0 ml administered thrice, 3 wk apart. This report demonstrates that a vaccine developed for equines against West Nile virus can be administered to birds.
How to translate text using browser tools
1 June 2005
AVIAN TITER DEVELOPMENT AGAINST WEST NILE VIRUS AFTER EXTRALABEL USE OF AN EQUINE VACCINE
Sharmie Johnson
ACCESS THE FULL ARTICLE
Journal of Zoo and Wildlife Medicine
Vol. 36 • No. 2
June 2005
Vol. 36 • No. 2
June 2005
birds of prey
corvids
seroconversion
titer
vaccine
West Nile virus